The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,428,999 in first-year total cost, median $567,909.
Most frequent study sections
- Clinical, Treatment and Health Services Research Study Section[AA-3]13
- Drug Discovery for the Nervous System Study Section[DDNS]1
- Risk, Prevention and Intervention for Addictions Study Section[RPIA]1
- Special Emphasis Panel[ZAA1 DD (03)]1
- Special Emphasis Panel[ZAA1 GG (02)]1
Most frequent institutions
- STATE UNIVERSITY OF NEW YORK AT BUFFALO2
- UNIVERSITY OF PENNSYLVANIA2
- YALE UNIVERSITY2
- BROWN UNIVERSITY1
- CHESTNUT HEALTH SYSTEMS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Recovery Management Checkup for Primary Care (RMC-PC) vs. Screening Brief Intervention and Referral to Treatment (SBIRT) Experiment1R01AA024440-01 | SCOTT, CHRISTY K | CHESTNUT HEALTH SYSTEMS, INC., IL | $538,957 | AA |
| 2016 | Affect Regulation Training (ART)for Alcohol Use Disorder: A Stage II Efficacy Trial1R01AA024628-01A1 | BRADIZZA, CLARA MARGARETSTASIEWICZ, PAUL R | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $693,739 | ZAA1 |
| 2016 | Implementation of Technology-Based Evaluation of Motivational Interviewing2R01AA018673-06A1 | ATKINS, DAVID CHARLESNARAYANAN, SHRIKANTH | UNIVERSITY OF WASHINGTON, WA | $647,176 | AA |
| 2016 | Zonisamide treatment of alcohol use disorder: an evaluation of efficacy and mechanism of action1R01AA024466-01 | ARIAS, ALBERT JOSEPH | YALE UNIVERSITY, CT | $589,937 | AA |
| 2016 | Efficacy and Mechanisms of CBT4CBT for Alcohol Use Disorders1R01AA024122-01A1 | KILUK, BRIAN D. | YALE UNIVERSITY, CT | $543,855 | AA |
| 2016 | Hierarchical Modeling of Alcohol Treatment Outcomes of Group Therapy2R01AA019663-04A1 | PADDOCK, SUSAN M. | RAND CORPORATION, CA | $258,655 | AA |
| 2015 | Adaptive Interventions for Problem Drinkers1R01AA022714-01A1 | MORGENSTERN, JON | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY | $711,636 | ZAA1 |
| 2015 | Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders1R01AA023540-01A1 | BROWN, E SHERWOODSALLOUM, IHSAN M | UT SOUTHWESTERN MEDICAL CENTER, TX | $700,994 | AA |
| 2015 | Interventions for Unemployed Hazardous Drinkers1R01AA023502-01 | PETRY, NANCY M | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT | $655,387 | AA |
| 2015 | Pretreatment Changes in Drinking: A Test of a Tailored Treatment Approach1R01AA023179-01A1 | STASIEWICZ, PAUL R | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $567,909 | AA |
| 2015 | Data-Based Methods for Just-In-Time Adaptive Interventions in Alcohol Use1R01AA023187-01A1 | MURPHY, SUSAN A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $485,356 | AA |
| 2014 | Impact of enhancements to smartphone-based continuing care for alcohol dependence1R01AA022595-01A1 | GUSTAFSON, DAVID HMCKAY, JAMES R. | UNIVERSITY OF PENNSYLVANIA, PA | $668,933 | AA |
| 2014 | Randomized Trial of Intensive MI to Improve Drinking Outcomes Among Women1R01AA022857-01A1 | POLCIN, DOUGLAS L | PUBLIC HEALTH INSTITUTE, CA | $648,028 | AA |
| 2014 | Pharmacogenetic Analysis of Topiramate Treatment of AUD1R01AA023192-01 | KRANZLER, HENRY RICHARD | UNIVERSITY OF PENNSYLVANIA, PA | $539,774 | AA |
| 2014 | Peripheralized CB1 antagonists for ALD1R01AA022235-01A1 | MAITRA, RANGAN | RESEARCH TRIANGLE INSTITUTE, NC | $451,504 | DDNS |
| 2014 | Robust person-centered longitudinal data analysis for clinical alcohol research1R01AA023248-01 | STEINLEY, DOUGLAS L | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $381,846 | RPIA |
| 2014 | Intervention Ingredients and Mechanisms of an Efficacious Motivational Interview1R01AA023194-01 | MAGILL, MOLLY | BROWN UNIVERSITY, RI | $345,313 | AA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.